Autologous adipose-derived mesenchymal stem cells (ADMSc)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous adipose-derived mesenchymal stem cells (ADMSc), covering 2014-05-13 to 2014-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary Fibrosis [Phase 1, Phase 2]